CASR and Hypocalcemia: NPS R-568 has been shown to decrease PTH secretion and increase calcitonin secretion through its activity at CaR on parathyroid cells and C cells, and these effects leads to hypocalcemia due to a reduced efflux of Ca2+ from bone [22, 23, 56].